Ecolab Deutschland GmbH
Pharmaceutical Companies · Mettmann
Ecolab Deutschland GmbH is a pharmaceutical company based in Mettmann, North Rhine-Westphalia, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Ecolab Deutschland GmbH Address & Contact
Company profile
1923
Founded
45.000+ (global)
Employees
Ecolab Deutschland GmbH at a Glance
Ecolab Deutschland GmbH is the German subsidiary of the U.S.-based company Ecolab Inc., which operates in over 170 countries and specializes in water treatment solutions, hygiene management, and infection prevention. The company is headquartered in Mettmann, North Rhine-Westphalia, where it plays a central role in the German operations strategy, particularly regarding regulation and market adaptation. Ecolab is committed to supporting the industry in its efficiency and sustainability efforts through innovative products and services.
Hygiene and Infection Prevention in Healthcare
In the pharmaceutical and medical sector, Ecolab plays a crucial role by providing high-quality disinfectants, thorough hand hygiene solutions, and effective cleaning products. These products are specifically designed for use in hospitals, nursing homes, and production facilities in the pharmaceutical industry to meet the highest hygiene standards. The best-known brands include:
- Skinman: A range of hand disinfectant solutions based on dermatologically tested formulations, recognized for their skin compatibility.
- Incidin: Highly effective surface disinfectants that reliably kill bacteria, viruses, and fungi, drying quickly to accelerate decontamination processes.
In addition, Ecolab is active in the area of Clean-in-Place (CIP) systems, which are essential for the cleaning and disinfection of piping systems in pharmaceutical manufacturing facilities. The use of these technologies ensures consistent product quality and helps comply with the strict regulatory requirements of the food and pharmaceutical industries.
Mettmann Location
Mettmann is home to the administration of Ecolab Deutschland and thus forms the backbone for nationwide distribution and customer service. The strategic location near Düsseldorf and in the heart of the Rhineland enables the company to access numerous pharmaceutical and healthcare companies. Here, not only multinational corporations are located, but also innovative start-ups involved in research and development. This regional concentration fosters collaboration and exchange within the industry, which is advantageous for Ecolab.
Another advantage of the Mettmann location is the excellent infrastructure, which ensures efficient logistics solutions and customer proximity. This allows the company to respond more quickly to market demands and develop tailored solutions for its customers.
Regulatory Classification and Quality Standards
Ecolab is not only active in product development but also in ensuring compliance with various regulatory standards that are important for the healthcare and food industries. These include compliance with the European Biopesticide Regulation and the requirements of the Robert Koch Institute (RKI). These rigorous regulations ensure that all products from Ecolab are not only effective but also safe to use.
The company continuously invests in research and development to incorporate the latest scientific findings into product development. Innovation cycles are short, and regular product testing is conducted to ensure effectiveness and safety.
Market Analysis and Regional Significance
Ecolab has established itself as a trusted partner in hygiene management in Germany. The regional significance of the company is evident not only in the number of employees working in Mettmann and the surrounding area but also in the strategic partnerships established with local health organizations and educational institutions. These collaborations enable the exchange of expertise and the development of further innovative solutions tailored to the specific needs of the German market.
Ecolab's presence in Germany significantly contributes to the advancement of hygiene and resource management practices in the industry, thus securing not only business success but also the health of the population.
More pharmaceutical companies in Germany | pharmaceutical companies in Mettmann | pharmaceutical companies in NRW
Frequently asked questions about Ecolab Deutschland GmbH
What does Ecolab Deutschland GmbH do?
Die Ecolab Deutschland GmbH agiert weltweit im Bereich Reinigung and Hygiene of verschiedenen facilityen. Ecolab Healthcare is on the Reinigung in Krankenhäuser spezialisiert. Sie bieten Schulungen of Mitarattern for den Hygiene-Bereich an and produces and verkont Reinigungs- and Desinfektionswithtel for Hände, Flächen and medizinische Geräte.
More Pharmaceutical Companies in Mettmann
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies by location
About Pharmaceutical Companies
Germany is one of the world's leading pharmaceutical nations, home to more than 1,000 pharmaceutical businesses employing approximately 130,000 people (vfa 2023). Companies operating in this sector develop, manufacture and distribute medicines across the entire value chain, from early-stage research and clinical trials through to market authorisation and commercial distribution. In Germany, every manufacturer of medicinal products must hold a manufacturing authorisation (Herstellungserlaubnis) issued under Section 13 of the AMG (Arzneimittelgesetz, Germany's Medicinal Products Act). Medicines may only be placed on the market after receiving approval from either BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Germany's Federal Institute for Drugs and Medical Devices, broadly comparable to the FDA in the United States or the MHRA in the United Kingdom) or the European Medicines Agency (EMA) via the centralised procedure. All manufacturing sites are subject to regular GMP (Good Manufacturing Practice) inspections carried out by the competent pharmaceutical supervisory authority of the relevant German federal state. The sector covers prescription-only medicines (Rx), non-prescription OTC products, generics, biosimilars and active pharmaceutical ingredients (APIs). This directory lists pharmaceutical manufacturers, marketers and licence holders across all German federal states with full contact details, addresses and phone numbers.
Germany's Pharmaceutical Industry
Germany is consistently ranked among the top five pharmaceutical markets worldwide, generating annual revenues exceeding EUR 50 billion and accounting for the largest share of pharmaceutical production in continental Europe. The industry is represented by two major associations: vfa (Verband Forschender Arzneimittelhersteller), which represents research-based companies, and BAH (Bundesverband der Arzneimittel-Hersteller), which represents the broader manufacturer base including OTC and self-medication products. German pharmaceutical companies cover the full spectrum from global innovator corporations and mid-sized specialty manufacturers to generic producers and biotech firms. The country is a world leader in active pharmaceutical ingredient (API) production, biologics manufacturing and pharmaceutical chemistry. Key therapeutic areas of strength include oncology, cardiovascular medicine, immunology, neuroscience and rare diseases. Germany also serves as a significant export hub, with pharmaceutical products among the country's leading export categories. The sector benefits from a highly skilled workforce, world-class university research institutions and a dense network of research hospitals (Universitätsklinika) that facilitate clinical trial activity.
Regulatory Framework: BfArM, EMA and the AMG
The legal foundation for pharmaceutical activity in Germany is the Arzneimittelgesetz (AMG, German Medicinal Products Act), which regulates the authorisation, manufacture, import, distribution, labelling and pharmacovigilance of medicinal products. For English-speaking readers unfamiliar with the German regulatory landscape: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is the national competent authority responsible for approving medicines marketed only in Germany, supervising narcotics, and maintaining the pharmacovigilance database. BfArM is a higher federal authority (Bundesoberbehörde) subordinate to the Federal Ministry of Health (Bundesministerium für Gesundheit). For medicines approved via the centralised EU procedure, the European Medicines Agency (EMA) grants a single marketing authorisation valid in all 27 EU member states. Germany is also home to the Paul-Ehrlich-Institut (PEI), a second federal authority that specifically handles biological medicines including vaccines, blood products and gene therapy products. Manufacturing sites are inspected by state-level pharmaceutical supervisory authorities (Landesbehörden) to verify GMP compliance, with findings entered into the EudraGMDP database operated by the EMA.
Regional Pharmaceutical Clusters in Germany
Germany's pharmaceutical industry is geographically distributed across several major regional clusters. The Rhine-Main area around Frankfurt and Leverkusen in North Rhine-Westphalia is home to some of Germany's largest pharmaceutical sites, including facilities belonging to global corporations with long histories in German chemistry and pharmaceuticals. Bavaria (particularly Munich, Penzberg and Marburg) is a second major hub, especially strong in biotechnology and biologics production. Baden-Württemberg, including cities such as Mannheim, Heidelberg and Biberach an der Riss, is home to several significant research-based manufacturers. Hamburg and the northern German region have a cluster of specialty and generic manufacturers. Berlin has a growing biotech scene connected to its research universities and the Charité hospital. Hesse is notable for its proximity to Frankfurt's logistics infrastructure and several major API manufacturers. Smaller but significant clusters exist in Saxony (Leipzig, Dresden) and Lower Saxony, benefiting from proximity to university research centres and historically established chemical industry sites.
Drug Classes and Product Segments
German pharmaceutical companies cover all major drug classes. Prescription (Rx) products account for the largest share of revenue; generics manufacturers such as Stada, ratiopharm (Teva) and Hexal produce chemically equivalent alternatives after patent expiry, significantly reducing costs for the healthcare system. Biologics and biosimilars are gaining ground rapidly: monoclonal antibodies, insulin analogues and recombinant growth factors require specialised biotech manufacturing facilities. OTC products (over-the-counter), i.e. medicines available without a prescription, represent a multi-billion-euro market served by companies such as Bayer Consumer Health, Stada and Klosterfrau. Homeopathic preparations, herbal medicines and dietary supplements form further regulated segments. Digitalisation is increasingly shaping the sector: Digital Health Applications (DiGA) have been reimbursable since 2020, and AI-assisted drug development is significantly shortening time-to-market.
What does a pharmaceutical company do?
Pharmaceutical companies develop, produce and distribute medicines. They cover the entire value chain from research and clinical trials through to market launch and distribution. In Germany, they are supervised by BfArM (the Federal Institute for Drugs and Medical Devices, comparable to the FDA or MHRA).
How are pharmaceutical companies regulated in Germany?
Pharmaceutical companies in Germany must hold a manufacturing authorisation under Section 13 of the AMG (German Medicinal Products Act). All authorised medicines require approval from either BfArM or the European Medicines Agency (EMA). Regular GMP (Good Manufacturing Practice) inspections ensure quality standards are maintained.
Where can I find contact details for pharmaceutical companies in Germany?
Industry associations such as vfa (Association of Research-Based Pharmaceutical Companies) and BPI (Federal Association of the German Pharmaceutical Industry) maintain member directories. Many companies also list their key contacts directly on their websites. Sanoliste provides a searchable directory of pharmaceutical companies in Germany sorted by federal state and city.
How many pharmaceutical companies are there in Germany?
Germany is home to more than 1,000 pharmaceutical companies employing approximately 130,000 people, according to vfa (the Association of Research-Based Pharmaceutical Companies) 2023 data. The sector includes multinational corporations, mid-sized specialty firms, generic manufacturers and biotech startups.
What is BfArM and what does it regulate?
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is Germany's Federal Institute for Drugs and Medical Devices. It is a higher federal authority within the portfolio of the Federal Ministry of Health and is responsible for approving medicines for the German market, monitoring drug safety (pharmacovigilance), regulating narcotics and controlled substances, and overseeing medical devices in Germany. It is broadly comparable to the FDA in the United States or the MHRA in the United Kingdom.
What is the difference between BfArM approval and EMA approval?
Medicines in Germany can be approved through two main routes. BfArM grants national marketing authorisations valid in Germany, or decentralised and mutual recognition procedure approvals valid in multiple EU states. The EMA (European Medicines Agency) grants centralised marketing authorisations valid in all 27 EU member states simultaneously, typically used for innovative biologic medicines, oncology drugs and products for rare diseases.
What does GMP mean in the context of German pharmaceutical manufacturing?
GMP stands for Good Manufacturing Practice. In Germany and the EU, GMP compliance is a legal requirement for all pharmaceutical manufacturers under the AMG and the EU GMP Guidelines (EudraLex Volume 4). GMP covers all aspects of production including premises, equipment, personnel qualification, process validation, documentation and quality control. Compliance is verified by regular inspections from the competent state pharmaceutical supervisory authority.